Centers for Disease Control and Prevention. Available from: http://www.cdc.gov/vhf/ebola/. Accessed December, 2014.
Fusco FM, Schilling S, De Iaco G, Brodt HR, Brouqui P, Maltezou HC, et al. Infection control management of patients with suspected highly infectious diseases in emergency departments: data from a survey in 41 facilities in 14 European countries. BMC Infect Dis 2012;28:12–27.Google Scholar
Centers for Disease Control and Prevention. Interim guidance for specimen collection, transport, testing, and submission for persons under investigation for Ebola virus disease in the United States. Available from: http://www.cdc.gov/vhf/ebola/hcp/interim-guidance-specimen-collection-submission-patients-suspected-infection-ebola.html. Accessed December, 2014.
Centers for Disease Control and Prevention. Interim guidance for managing patients with suspected viral hemorrhagic fever in US. hospitals. Available from: http://www.cdc.gov/HAI/pdfs/bbp/VHFinterimGuidance05_19_05.pdf. Accessed December, 2014.
Ontario Agency for Health Protection and Promotion. Available from: http://www.publichealthontario.ca/en/eRepository/Ebola_Virus_Disease_ (EVD) _Sample_Collection_Submission_Guide.pdf. Accessed December, 2014.
Ukkonen P, Korpela J, Suni J, Hedman K. Inactivation of human immunodeficiency virus in serum specimens as a safety measure for diagnostic immunoassays. Eur J Clin Microbiol Infect Dis 1988;7:518–23.PubMedCrossrefGoogle Scholar
Maltezou HC, Fusco FM, Schilling S, De Iaco G, Gottschalk R, Brodt HR, et al. Infection control practices in facilities for highly infectious diseases across Europe. J Hosp Infect 2012;81:184–91.CrossrefGoogle Scholar
Word Health Organization. Infection prevention and control guidance for care of patients in health-care settings, with focus on Ebola. Available from: http://www.who.int/csr/resources/publications/ebola/filovirus_infection_control/en/. Accessed December, 2014.
NYS/NYC laboratory guidelines for handling specimens from patients with suspected or confirmed Ebola virus disease. Available from: https://www.health.ny.gov/diseases/communicable/ebola/docs/lab_guidelines.pdf. Accessed December, 2014.
Bhagat CI, Lewer M, Prins A, Beilby JP. Effects of heating plasma at 56 degrees C for 30 min and at 60 degrees C for 60 min on routine biochemistry analytes. Ann Clin Biochem 2000;37:802–4.PubMedGoogle Scholar
Lau R, Wang A, Chong-Kit A, Ralevski F, Boggild AK. Evaluation of Ebola virus inactivation procedures for Plasmodium falciparum malaria diagnostics. J Clin Microbiol 2015;53:1387–90.PubMedCrossrefGoogle Scholar
Hersberger M, Nusbaumer C, Scholer A, Knöpfli V, von Eckardstein A. Influence of practicable virus inactivation procedures on tests for frequently measured analytes in plasma. Clin Chem 2004;50:944–6.CrossrefGoogle Scholar
About the article
Published Online: 2015-06-06
Published in Print: 2015-11-01